Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review.

Steiner MC, Roubenoff R, Tal-Singer R, Polkey MI.

Thorax. 2012 Dec;67(12):1102-9. doi: 10.1136/thoraxjnl-2012-201765. Epub 2012 May 5. Review.

PMID:
22561528
2.

Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?

Velema MS, Kwa BH, de Ronde W.

Curr Opin Pulm Med. 2012 Mar;18(2):118-24. doi: 10.1097/MCP.0b013e32834e9001. Review.

PMID:
22189453
3.

Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation.

Man WD, Kemp P, Moxham J, Polkey MI.

Clin Sci (Lond). 2009 Aug 24;117(8):281-91. doi: 10.1042/CS20080660. Review.

PMID:
19689433
4.

Skeletal muscle function in COPD.

Casaburi R.

Chest. 2000 May;117(5 Suppl 1):267S-71S. Review.

PMID:
10843945
5.

Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.

Dong Y, Li Y, Sun Y, Mao J, Yao F, Tian Y, Wang L, Li L, Li S, Li J.

BMC Complement Altern Med. 2015 Mar 10;15:51. doi: 10.1186/s12906-015-0559-x.

6.

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD.

Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST. Review.

7.

Muscle function in COPD: a complex interplay.

Donaldson AV, Maddocks M, Martolini D, Polkey MI, Man WD.

Int J Chron Obstruct Pulmon Dis. 2012;7:523-35. doi: 10.2147/COPD.S28247. Epub 2012 Aug 17. Review.

8.

Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease.

Passey SL, Hansen MJ, Bozinovski S, McDonald CF, Holland AE, Vlahos R.

Pharmacol Ther. 2016 Oct;166:56-70. doi: 10.1016/j.pharmthera.2016.06.013. Epub 2016 Jun 29. Review.

9.

[Peripheral muscle dysfunction in chronic obstructive pulmonary disease].

Roca M, Mihăescu T.

Pneumologia. 2012 Jul-Sep;61(3):178-82. Review. Romanian.

PMID:
23173381
10.

Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Rabinovich RA, Vilaró J.

Curr Opin Pulm Med. 2010 Mar;16(2):123-33. doi: 10.1097/MCP.0b013e328336438d. Review.

11.

Skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Mador MJ, Bozkanat E.

Respir Res. 2001;2(4):216-24. Epub 2001 May 2. Review.

12.

Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.

Kim HC, Mofarrahi M, Hussain SN.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):637-58. Review.

13.
14.

Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Barreiro E, Gea J.

Chron Respir Dis. 2016 Aug;13(3):297-311. doi: 10.1177/1479972316642366. Epub 2016 Apr 6. Review.

15.

Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target.

Meyer A, Zoll J, Charles AL, Charloux A, de Blay F, Diemunsch P, Sibilia J, Piquard F, Geny B.

Exp Physiol. 2013 Jun;98(6):1063-78. doi: 10.1113/expphysiol.2012.069468. Epub 2013 Feb 1. Review.

16.

Should all patients with COPD be exercise trained?

Ribeiro F, Thériault ME, Debigaré R, Maltais F.

J Appl Physiol (1985). 2013 May;114(9):1300-8. doi: 10.1152/japplphysiol.01124.2012. Epub 2013 Feb 14. Review.

PMID:
23412902
17.

Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease.

Calvert LD, Shelley R, Singh SJ, Greenhaff PL, Bankart J, Morgan MD, Steiner MC.

Am J Respir Crit Care Med. 2008 May 15;177(10):1090-4. doi: 10.1164/rccm.200707-1032OC. Epub 2008 Feb 8.

PMID:
18263802
18.

Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease.

Daga MK, Khan NA, Malhotra V, Kumar S, Mawari G, Hira HS.

Nutr Clin Pract. 2014 Apr;29(2):238-45. doi: 10.1177/0884533614522832. Epub 2014 Feb 19.

PMID:
24552826
19.

Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease: a systematic review.

Robles PG, Mathur S, Janaudis-Fereira T, Dolmage TE, Goldstein RS, Brooks D.

J Cardiopulm Rehabil Prev. 2011 Jan-Feb;31(1):11-24. doi: 10.1097/HCR.0b013e3181ebf302. Review.

PMID:
20724932
20.

Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.

Barreiro E, Gea J.

Transl Res. 2015 Jan;165(1):61-73. doi: 10.1016/j.trsl.2014.04.006. Epub 2014 Apr 15. Review.

PMID:
24794953

Supplemental Content

Support Center